
    
      This is a randomized, multicenter study. Patients are stratified according to participating
      center, gender, distance of the distal tumor margin from the dentate line (> 5 cm vs ≤ 5 cm),
      age (< 70 vs ≥ 70), neoadjuvant chemoradiotherapy (yes vs no), and distant metastasis (M0 vs
      M1). Patients are randomized to 1 of 3 treatment arms.
    
  